Literature DB >> 9270811

Immunosuppressive drugs and pregnancy: experimental and clinical data.

E Albengres1, H Le Louet, J P Tillement.   

Abstract

Mesh:

Substances:

Year:  1997        PMID: 9270811     DOI: 10.1016/s0041-1345(97)00450-8

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

Review 1.  Treating inflammatory bowel disease during pregnancy: risks and safety of drug therapy.

Authors:  W Connell; A Miller
Journal:  Drug Saf       Date:  1999-10       Impact factor: 5.606

2.  Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Robert P Baughman; Keith C Meyer; Ian Nathanson; Luis Angel; Sangeeta M Bhorade; Kevin M Chan; Daniel Culver; Christopher G Harrod; Mary S Hayney; Kristen B Highland; Andrew H Limper; Herbert Patrick; Charlie Strange; Timothy Whelan
Journal:  Chest       Date:  2012-11       Impact factor: 9.410

3.  Synthesis of three-arm block copolymer poly(lactic-co-glycolic acid)-poly(ethylene glycol) with oxalyl chloride and its application in hydrophobic drug delivery.

Authors:  Xiaowei Zhu; Chao Liu; Jianwei Duan; Xiaoyu Liang; Xuanling Li; Hongfan Sun; Deling Kong; Jing Yang
Journal:  Int J Nanomedicine       Date:  2016-11-15

4.  Outcome of pregnancy after organ transplantation: a retrospective survey in Italy.

Authors:  Roberto Miniero; Irene Tardivo; Emilio Sergio Curtoni; Fabrizio Bresadola; Gilberto Calconi; Antonino Cavallari; Paolo Centofanti; Franco Filipponi; Alessandro Franchello; Claudio Goggi; Ennio La Rocca; Carmelo Mammana; Antonio Nino; Francesco Parisi; Enrico Regalia; Alberto Rosati; Giuseppe Paolo Segoloni; Gisella Setti; Paola Todeschini; Carla Tregnaghi; Paola Zanelli; Anna Maria Dall'Omo
Journal:  Transpl Int       Date:  2004-11-26       Impact factor: 3.782

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.